BCL2 and acute myeloid leukemia: Additionally, upon interacting with fibronectin on stromal cells, high levels of α4β1 integrin, besides enabling HSC retention in the BM, mediate chemoresistance in AML cells via the PI3K/AKT/BCL-2 signaling pathway and are often associated with BM minimal residual disease [68,69].